Omega Healthcare Investors Inc financial data

Symbol
OHI on NYSE
Industry
Real Estate Investment Trusts
Location
303 International Circle,, Suite 200, Hunt Valley, MD
State of incorporation
Maryland
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 146 % -5.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 258M shares +5.3%
Common Stock, Shares, Outstanding 254M shares +5.41%
Entity Public Float 7.4B USD +12.1%
Common Stock, Value, Issued 25.4M USD +5.41%
Weighted Average Number of Shares Outstanding, Basic 249M shares +5.56%
Weighted Average Number of Shares Outstanding, Diluted 262M shares +6.27%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 977M USD +14.6%
General and Administrative Expense 82.5M USD +7.25%
Income Tax Expense (Benefit) 10.5M USD +311%
Earnings Per Share, Basic 1.34 USD/shares +28.8%
Earnings Per Share, Diluted 1.32 USD/shares +28.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.2M USD -90%
Operating Lease, Right-of-Use Asset 30.2M USD +69.1%
Goodwill 644M USD -0.01%
Assets 8.85B USD -5.91%
Liabilities 4.95B USD -11.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 34.3M USD -16.9%
Retained Earnings (Accumulated Deficit) 3.86B USD +9.27%
Stockholders' Equity Attributable to Parent 3.71B USD +2.39%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.9B USD +2.31%
Liabilities and Equity 8.85B USD -5.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 151M USD +36%
Net Cash Provided by (Used in) Financing Activities -186M USD -11.8%
Net Cash Provided by (Used in) Investing Activities -47.5M USD -1886%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 254M shares +5.41%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -81.7M USD -56.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 39.1M USD -89%
Interest Paid, Excluding Capitalized Interest, Operating Activities 58.4M USD -4.95%
Deferred Tax Assets, Valuation Allowance 1.98M USD -7.44%
Deferred Tax Assets, Gross 15.5M USD
Operating Lease, Liability 31.6M USD +65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 321M USD +13.9%
Deferred Tax Assets, Operating Loss Carryforwards 2.05M USD -4.21%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 10.6M USD +308%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 6.95B USD +6.51%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 305M USD -7.4%
Share-based Payment Arrangement, Expense 36M USD +15.8%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%